Drug Profile
Prothrombin complex - Guangdong Weilun Biological
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Guangdong Weilun Biological
- Class Blood coagulation factors
- Mechanism of Action Blood coagulation factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Blood coagulation disorders
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for clinical-Phase-Unknown development in Blood-coagulation-disorders in China (Parenteral)
- 29 Jul 2016 Clinical trials in Coagulation disorders in China (Parenteral)